Quantitative neuropathology associated with chronic manganese exposure in South African mine workers.

Implications of glial nitric oxide in neurodegenerative diseases. Front Cell Neurosci (2015) 0.93

"Manganese-induced neurotoxicity: a review of its behavioral consequences and neuroprotective strategies". BMC Pharmacol Toxicol (2016) 0.86

Cellular manganese content is developmentally regulated in human dopaminergic neurons. Sci Rep (2014) 0.82

Ex vivo magnetic resonance imaging in South African manganese mine workers. Neurotoxicology (2015) 0.79

Effects of Nano-MnO2 on dopaminergic neurons and the spatial learning capability of rats. Int J Environ Res Public Health (2014) 0.76

Inducible nitric oxide synthase gene methylation and parkinsonism in manganese-exposed welders. Parkinsonism Relat Disord (2015) 0.75

Neuromythology of Manganism. Curr Epidemiol Rep (2015) 0.75

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci (1973) 7.85

Reduced uptake of [¹⁸F]FDOPA PET in asymptomatic welders with occupational manganese exposure. Neurology (2011) 2.53

Manganese poisoning in Moroccan miners. Br J Ind Med (1955) 2.41

Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders. Neurology (2005) 2.41

Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein. Proc Natl Acad Sci U S A (1999) 2.30

Role of manganese in neurodegenerative diseases. J Trace Elem Med Biol (2011) 1.73

Long-term exposure to "low levels" of manganese oxides and neurofunctional changes in ferroalloy workers. Neurotoxicology (1999) 1.56

Manganese encephalopathy: utility of early magnetic resonance imaging. Br J Ind Med (1993) 1.53

Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain. Acta Neuropathol (1986) 1.52

Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Br J Ind Med (1989) 1.37

Manganese and calcium efflux kinetics in brain mitochondria. Relevance to manganese toxicity. Biochem J (1990) 1.28

Loss of mitochondrial complex I activity potentiates dopamine neuron death induced by microtubule dysfunction in a Parkinson's disease model. J Cell Biol (2011) 1.28

Manganese uptake and efflux in cultured rat astrocytes. J Neurochem (1992) 1.26

Oxidative damage and neurodegeneration in manganese-induced neurotoxicity. Toxicol Appl Pharmacol (2009) 1.23

Increased risk of parkinsonism associated with welding exposure. Neurotoxicology (2012) 1.23

Manganese induces oxidative impairment in cultured rat astrocytes. Toxicol Sci (2007) 1.20

Manganese, iron, and total particulate exposures to welders. J Occup Environ Hyg (2010) 1.20

Basal ganglia intensity indices and diffusion weighted imaging in manganese-exposed welders. Occup Environ Med (2012) 1.17

Neuropsychiatric effects of manganese on mood. Neurotoxicology (1999) 1.02

Estimation of particulate mass and manganese exposure levels among welders. Ann Occup Hyg (2010) 1.01

Prospective study on neurotoxic effects in manganese-exposed bridge construction welders. Neurotoxicology (2011) 1.00

Astrocytes and manganese neurotoxicity. Neurochem Int (2002) 1.00

Nervous system effects of occupational manganese exposure on South African manganese mineworkers. Neurotoxicology (2003) 0.93

The health implications of increased manganese in the environment resulting from the combustion of fuel additives: a review of the literature. J Toxicol Environ Health (1984) 0.91

Manganese disrupts astrocyte glutamine transporter expression and function. J Neurochem (2009) 0.90

Statistical modeling to determine sources of variability in exposures to welding fumes. Ann Occup Hyg (2011) 0.89

Role of glial cells in manganese neurotoxicity. J Appl Toxicol (2011) 0.86

Pharmacokinetic modeling of manganese. I. Dose dependencies of uptake and elimination. J Toxicol Environ Health A (2007) 0.81

Research capacity development in South African manganese mines to bridge exposure and neuropathologic outcomes. Neurotoxicology (2012) 0.81

Pharmacokinetic modeling of manganese. II. Hepatic processing after ingestion and inhalation. J Toxicol Environ Health A (2007) 0.80

Compensation for occupational diseases in the RSA. S Afr Med J (1987) 0.78

[Clinical aspects and pathological anatomy of chronic pyrolusite poisoning]. Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr (1954) 0.77